EMCURE Emcure Pharmaceuticals Limited
Healthcare
LTP
1,868.1
CHG · %
+4.35 (+0.23%)
VOL · TODAY
82.63K
PREV CLOSE
1,863.75
Today's range1,854.05 · 1,886.35
1,868.1
52-week range1,306.5 · 2,100.7
1,868.1
Loading candles…
Emcure Pharmaceuticals Ltd, incorporated in 1981, is a vertically integrated pharmaceutical company that develops, manufactures, and markets a diverse range of pharmaceutical products. Its offerings include differentiated and complex generics across several key therapeutic areas such as gynaecology, cardiovascular, vitamins, minerals and nutrients, HIV/AIDS, and oncology. The company operates globally with significant presence in India, Europe, and Canada. Emcure holds a leading position in the Indian Pharmaceutical Market (IPM), notably as the largest player in gynaecology within the IPM and is recognized among the top 10 companies in this market. It has strong research and development capabilities and focuses on addressing unmet medical needs within the pharmaceutical industry.
EMCURE is not part of any active scan today.
This page is a live market overview for Emcure Pharmaceuticals Limited (EMCURE) on the BSE. As a listed security, Emcure Pharmaceuticals Limited is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for EMCURE before placing trades on tick2trade.
As of the latest feed, EMCURE last traded at ₹1,868.1 on BSE, up ₹4.35 (0.23%) from the previous close of ₹1,863.75. Today's session range is ₹1,854.05 – ₹1,886.35, against a 52-week band of ₹1,306.5 – ₹2,100.7. Traded volume today stands at 82.63K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for EMCURE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether EMCURE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Emcure Pharmaceuticals Limited before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in EMCURE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated EMCURE option chain page linked from this overview.
// similar in healthcare326 total